1-8 of 8
Yoichiro Moriya
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2637: Mechanism of pertuzumab in combination with trastuzumab plus docetaxel therapy in a breast cancer xenograft model

Yoriko Yamashita-Kashima, Sei Shu, Keigo Yorozu, Yoichiro Moriya, Naoki Harada
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2637.
https://doi.org/10.1158/1538-7445.AM2015-2637
Published: 01 August 2015
View article titled, Abstract 2637: Mechanism of pertuzumab in combination with trastuzumab plus docetaxel therapy in a breast cancer xenograft model
Journal Articles

Abstract 2691: Role of trastuzumab in the combination treatment for a HER2-positive trastuzumab-resistant gastric cancer xenograft model

Sei Shu, Yoriko Yamashita-Kashima, Mieko Yanagisawa, Yoichiro Moriya, Naoki Harada
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2691.
https://doi.org/10.1158/1538-7445.AM2015-2691
Published: 01 August 2015
View article titled, Abstract 2691: Role of trastuzumab in the combination treatment for a HER2-positive trastuzumab-resistant gastric cancer xenograft model
Journal Articles

Abstract 3876: Role of Stat3 transcriptional activation in a preclinical mouse model of prostate cancer and potential as a therapeutic target

Marco A. De Velasco, Motoyoshi Tanaka, Kaori Fujimoto-Ouchi, Yoichiro Moriya, Yurie Kura, Yasuki Kobayashi, Yutaka Yamamoto, Yuji Hatanaka, Hiroyuki Kato, Kazuhiro Yoshikawa, Kazuto Nishio, Hirotsugu Uemura
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3876.
https://doi.org/10.1158/1538-7445.AM2012-3876
Published: 15 April 2012
View article titled, Abstract 3876: Role of Stat3 transcriptional activation in a preclinical mouse model of prostate cancer and potential as a therapeutic target
Journal Articles

Expression of Toll-Like Receptor 4 on Dendritic Cells Is Significant for Anticancer Effect of Dendritic Cell-Based Immunotherapy in Combination with an Active Component of OK-432, a Streptococcal Preparation

Masato Okamoto, Sachiko Furuichi, Yasuhiko Nishioka, Tetsuya Oshikawa, Tomoyuki Tano, Sharif Uddin Ahmed, Kiyoshi Takeda, Shizuo Akira, Yoshiki Ryoma, Yoichiro Moriya, Motoo Saito, Saburo Sone, Mitsunobu Sato
Journal: Cancer Research
Cancer Res (2004) 64 (15): 5461–5470.
https://doi.org/10.1158/0008-5472.CAN-03-4005
Published: 02 August 2004
View article titled, Expression of Toll-Like Receptor 4 on Dendritic Cells Is Significant for Anticancer Effect of Dendritic Cell-Based Immunotherapy in Combination with an Active Component of OK-432, a Streptococcal Preparation
Open the PDF for Expression of Toll-Like Receptor 4 on Dendritic Cells Is Significant for Anticancer Effect of Dendritic Cell-Based Immunotherapy in Combination with an Active Component of OK-432, a Streptococcal Preparation in another window
Journal Articles

Therapeutic effect of streptococcal agent OK-432 via toll-like receptor (TLR)4/MD-2 in the therapy for oral squamous cell carcinoma by UFT and OK-432 in combination with radiotherapy.

Mitsunobu Sato, Masato Okamoto, Takashi Bando, Koji Harada, Hideo Yoshida, Tomoyuki Tano, Sachiko Furuichi, Tetsuya Oshikawa, Sharif U. Ahmed, Yoichiro Moriya, Yoshiki Ryoma, Motoo Saito
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 506.
Published: 01 April 2004
View article titled, Therapeutic effect of streptococcal agent OK-432 via toll-like receptor (TLR)4/MD-2 in the therapy for oral squamous cell carcinoma by UFT and OK-432 in combination with radiotherapy.
Journal Articles

Involvement of Toll-like receptor 4 in the anti-tumor effect of intratumoral administration of dendritic cells followed by an active component of a streptococcal agent OK-432 against tumor-bearing mice

Masato Okamoto, Sachiko Furuichi, Tetsuya Oshikawa, Tomoyuki Tano, Sharif U. Ahmed, Yoichiro Moriya, Yoshiki Ryoma, Motoo Saito, Mitsunobu Sato
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1089–1090.
Published: 01 April 2004
View article titled, Involvement of Toll-like receptor 4 in the anti-tumor effect of intratumoral administration of dendritic cells followed by an active component of a streptococcal agent OK-432 against tumor-bearing mice
Journal Articles

Adoptive Immunotherapy by Pantropic Killer Cells Recovered from OK-432-injected Tumor Sites in Mice

Motoo Saito, Masaki Nanjo, Motoyuki Kataoka, Yoichiro Moriya, Yutaka Sugawara, Takeshi Yoshida, Nakao Ishida
Journal: Cancer Research
Cancer Res (1988) 48 (15): 4163–4167.
Published: 01 August 1988
View article titled, Adoptive Immunotherapy by Pantropic Killer Cells Recovered from OK-432-injected Tumor Sites in Mice
Open the PDF for Adoptive Immunotherapy by Pantropic Killer Cells Recovered from OK-432-injected Tumor Sites in Mice in another window
Journal Articles

Modulation of Cell Growth, Differentiation, and Production of Interleukin-3 by 1α,25-Dihydroxyvitamin D3 in the Murine Myelomonocytic Leukemia Cell Line WEHI-3

Junko Abe, Yoichiro Moriya, Motoo Saito, Yutaka Sugawara, Tatsuo Suda, Yasuho Nishii
Journal: Cancer Research
Cancer Res (1986) 46 (12_Part_1): 6316–6321.
Published: 01 December 1986
View article titled, Modulation of Cell Growth, Differentiation, and Production of Interleukin-3 by 1α,25-Dihydroxyvitamin D<sub>3</sub> in the Murine Myelomonocytic Leukemia Cell Line WEHI-3
Open the PDF for Modulation of Cell Growth, Differentiation, and Production of Interleukin-3 by 1α,25-Dihydroxyvitamin D<sub>3</sub> in the Murine Myelomonocytic Leukemia Cell Line WEHI-3 in another window